Burkholderia cepacia endophthalmitis, in a penicillin allergic patient, following a ranibizumab injection

BMJ Case Reports

Volumn , Issue , 2014, Pages

  Saffra, Norman ^a   Moriarty, Emily ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; DEXAMETHASONE; LEVOFLOXACIN; LUNCENTIS; NITROFURANTOIN; RANIBIZUMAB; UNCLASSIFIED DRUG; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; B SCAN; BACTERIUM CULTURE; BURKHOLDERIA CEPACIA INFECTION; CASE REPORT; CLINICAL FEATURE; DISEASE DURATION; DRUG EFFECT; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; HUMAN; NONHUMAN; OPHTHALMOSCOPY; PENICILLIN ALLERGY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SLIT LAMP; VERY ELDERLY; VISUAL ACUITY; VITRECTOMY; VITRITIS;

EID: 84896902824     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-202075     Document Type: Article

References (13)

1. Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol 1996;122:830-46.
2. Sachdeva V, Pathengay A, Joseph J, et al. Burkholderia cepacia endophthalmitis: clinico-microbiologic profile and outcomes. Retina 2011;31:1801-5.
3. Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995;74:167-70.
4. Craven DE, Moody B, Connolly MG, et al. Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med 1981;305:621-3. (Pubitemid 12201115)
5. Sobel JD, Hashman N, Reinherz G, et al. Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med 1982;73:183-6. (Pubitemid 13203913)
6. Englander M, Chen TC, Paschalis EI, et al. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates. Br J Ophthalmol 2013;97:460-5.
7. Ng DS, Kwok AK, Chan CW, et al. Intravitreal bevacizumab: safety of multiple doses from a single vial for consecutive patients. Hong Kong Med J 2012;18:488-95.
8. Lyall DA, Tey A, Foot B, et al. Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye (Lond) 2012;26:1517-26.
9. Moshfeghi AA. Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Semin Ophthalmol 2011;26:139-48.
10. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479-96.
11. Shimomura H, Matsuura M, Saito S, et al. Unusual interaction of a lipopolysaccharide isolated from Burkholderia cepacia with polymyxin B. Infect Immun 2003;71:5225-30. (Pubitemid 37070768)
12. Fiscella RG, Nguyen TK, Cwik MJ, et al. Aqueous and vitreous penetration of levofloxacin after oral administration. Ophthalmology 1999;106:2286-90. (Pubitemid 30191439)
13. Del Piero E, Pennett M, Leopold I. Pseudomonas cepacia endophthalmitis. Ann Ophthalmol 1985;17:753-6. (Pubitemid 16178502)